EPIDAUROS Biotechnologie AG.
EPIDAUROS Biotechnologie AG is a leading provider of pharmacogenetic consulting, genotyping and research services to the international pharmaceutical and biotechnology industries, contract research organizations and healthcare providers. The company's mission is to improve safety, efficacy and predictability in drug development and drug therapy. EPIDAUROS determines its customers' needs in the field of pharmacogenetics using an in-depth consultancy process. The development and conduct of genotyping assays for drug-metabolizing enzymes, drug transporters and drug targets (for example, receptors)--all performed under stringent quality standards--are a major activity at EPIDAUROS. The company offers its research services to academic and industrial partners for the development of innovative diagnostic solutions by using its intellectual property.
Arnold
Hans-Peter
HP
EPIDAUROS Biotechnologie AG, Am Neuland 1,82347 Bernried, Germany.
Kluge
Peter
P
Mauch
Simon
S
D001709:Biotechnology / Q000639:trends*; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D004345:Drug Industry / Q000639:trends*; D015507:Drugs, Investigational / Q000378:metabolism; D006801:Humans; D018973:Intellectual Property; D010597:Pharmacogenetics / Q000639:trends*
D015507:Drugs, Investigational